US2018236021A1PendingUtilityA1
Method, apparatus and compositions for the prophylaxis and treatment of colony collapse disorder
Est. expiryAug 26, 2031(~5.1 yrs left)· nominal 20-yr term from priority
Inventors:Francesca Del Vecchio
A61K 36/886A61K 36/88A23K 20/10A23K 20/105A01K 53/00A61K 36/53A01K 51/00A23K 20/163A23K 50/90A23K 20/147A61P 39/06A61P 3/02A61P 33/14A61P 31/10A61P 31/12A61K 36/185Y02P60/70Y02P60/00
42
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
The liquid solution or suspension comprises tonic and nutrient ingredients, mainly consisting of milk powder, sugars and lower organic acids, antioxidant and antiseptic ingredients contained in plant extracts and healing ingredients to bees, such as essential oils of thyme and oxalic acid.
Claims
exact text as granted — not AI-modified1 - 22 . (canceled)
23 . A liquid solution or suspension for prevention and treatment of Colony Collapse Disease (CCD), comprising:
a) a nutrition composition comprising a sugar, a C 2 -C 6 organic acid, and milk powder, and optionally yeasts; b) an antioxidant and antiseptic composition comprising an extract of Origanum vulgare and an extract of at least one plant selected from the group consisting of Crocus sativus, Pelargonium graveolens, Monarda citriodora, Myristica fragrans, and Origanum majorana; and c) a medicinal composition for bees comprising at least one selected from the group consisting of thymol and extracts of Thymus vulgaris, and at least one selected from the group consisting of extracts of Aloe arborescens, oxalic acid, extracts of Beta vulgaris cv. altissima, and mixtures thereof.
24 . The liquid solution or suspension according to claim 23 , wherein said nutrition composition comprises milk powder, acetic acid, tartaric acid, citric acid and one selected from the group consisting of glucose, fructose and a mixture of glucose and fructose,
25 . The liquid solution or suspension according to claim 24 , wherein said nutrition composition further comprises glycerin.
26 . The liquid solution or suspension according to claim 23 , wherein said liquid solution or suspension comprises an extract of Origanum vulgare and an extract of at least two selected from the group consisting of Crocus sativus extract; Pelargonium graveolens extract; Myristica fragrans extract; and Origanum majorana extract.
27 . The liquid solution or suspension according to claim 26 , further comprising extract of Monarda citriodora.
28 . The liquid solution or suspension according to claim 23 , herein said medicinal composition for bees comprises extracts of Thymus vulgaris, extracts of Aloe arborescens, and oxalic acid.
29 . The liquid solution or suspension according to claim 28 , wherein said medicinal composition for bees further comprises extract of Beta vulgaris altissima.Join the waitlist — get patent alerts
Track US2018236021A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.